title: Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlation.
abstract: The systemic administration of 89Sr has proven effective in the palliation of painful osseous metastases. Biodistribution studies with the gamma-emitter 85Sr suggest that both its uptake and retention are increased in bone metastases, where increased mineral turnover takes place. To study the pattern and nature of this process further, bones containing metastatic deposits were obtained from three patients who had previously been treated with 148 MBq of 89Sr. The bones were cut into 0.5-1.0 cm sections. The cut surfaces which faced together were marked with India ink, and adjacent sections were submitted for histology and autoradiography. Strontium deposition and retention were observed in regions which exhibited significant osteoblastic activity, mostly in areas adjacent to metastatic deposits, but also in subchondral and endosteal locations, as well as in an area corresponding to a pathological fracture with callus formation. With these exceptions, strontium deposition was not observed in histologically normal bone or within the marrow. Our findings demonstrate directly the selective nature of accumulation and retention of 89Sr and confirm previous clinical impressions.
authors.affiliation: Department of Radiation Oncology, Wayne State University, Detroit, Michigan, USA.
authors.forename: E
authors.initials: E
authors.lastname: Ben-Josef
authors.forename: D R
authors.initials: DR
authors.lastname: Lucas
authors.forename: S
authors.initials: S
authors.lastname: Vasan
authors.forename: A T
authors.initials: AT
authors.lastname: Porter
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy* / Q000556:secondary*; D001706:Biopsy; D001859:Bone Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D013326:Strontium Radioisotopes / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014018:Tissue Distribution
chemical_list: D013326:Strontium Radioisotopes